Search

everythinglearnresearchcommunity

for

Search:↓

Thymectomy and high-dose prednisolone improved hair loss in a woman with alopecia areata.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The role of γδT-cells in causing alopecia areata remains unclear.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The treatment improved hair color in most vitiligo patients without major side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

A rare case of lupus linked to thymoma shows complex diagnosis and management challenges.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Nude mice are hairless due to a shared defect affecting both skin and thymus, not just thymic issues.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

Removing the liver tumor improved the patient's skin condition and hair growth.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

IL-18 signaling helps mature Tregs move into the thymus.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

Enhancing Tregs can protect against alopecia areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.